Mohan Pankaj 4
4 · Sonnet BioTherapeutics Holdings, Inc. · Filed Oct 27, 2023
Insider Transaction Report
Form 4
Mohan Pankaj
DirectorChairman, President and CEO
Transactions
- Purchase
Common Stock
2023-10-27+34,375→ 59,526 total - Purchase
Warrant to Purchase Common Stock
2023-10-27+68,750→ 68,750 totalExercise: $1.60From: 2023-10-27Exp: 2028-10-27→ Common Stock (68,750 underlying)
Holdings
- 3,021(indirect: By Mohan Family Office)
Common Stock
- 25(indirect: By Children)
Common Stock
Footnotes (4)
- [F1]Reporting Person purchased 34,375 shares of common stock and 68,750 warrants to purchase 68,750 shares of common stock pursuant to an underwritten public offering by the Issuer at $1.60 per share and accompanying two warrants. The offering closed on October 27, 2023.
- [F2]Includes unvested restricted stock units.
- [F3]All amounts reflect the 1:22 reverse stock split effective as of August 31, 2023.
- [F4]Reporting Person jointly exercises dispositive and voting power over the securities owned by the Mohan Family Office.